Fabrication and Characterization of Degradable Biomaterial Block Polymer PLGA Nanoparticles Modified by MePEG

Abstract:

The block polymer methoxy(polyethylene glycol)-poly(dl-lactide-co-glycolic acid) (MePEG-PLGA) nanoparticles were fabricated by modified spontaneous emulsification/solvent evaporation method, and further characterized their shape, size, zeta potential, glass transition temperature and other items by scanning electron microscopy, laser granulometry, differential scanning calorimetry (DSC), fourier transform infrared spectrometer and differential scanning calorimeter. Meanwhile, the effects of cytotoxicity of MePEG-PLGA nanoparticles on human ARPE-19 cells. The results indicated that the mean size of MePEG-PLGA nanoparticles was about 368.1nm, zeta potential was -32.6mV in distilled water and the start of glass transition temperature 26.75 centigrade degree. The fabricated MePEG-PLGA nanoparticles had narrow size distribution and were block polymer of PEG and PLGA detected by fourier transform infrared spectrometer and have good physical- and chemical-characterization. Additionally, no cytotoxicity was found for the MePEG-PLGA nanoparticles on human ARPE-19 cells. These results indicated that MePEG-PLGA nanoparticles have good biocompatibility and could be applied in drug delivery.

• Periodical: Advanced Materials Research (Volume 548)
• Pages: 128-132
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.548.128
• Online since: July 2012
• Authors: Da Dong Guo, Hong Sheng Bi, Xiao Feng Xie
• Keywords: Nanoparticle, Poly(dl-lactide-co-glycolic acid), Polyethylene Glycol (PEG), Spontaneous Emulsification/Solvent Evaporation

References

[1] K. Sonaje, J L. Italia, G. Sharma, V. Bhardwaj, K. Tikoo and M. N. Kumar, Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats, Pharm. Res. 24 (2007).

DOI: 10.1007/s11095-006-9207-y

[2] A. Mahapatro and D.K. Singh, Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J. Nanobiotechnology. 28 (2011) 55.

DOI: 10.1186/1477-3155-9-55

[3] G. Mittal, D.K. Sahana, V. Bhardwaj and M. N. Kumar, Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo, J. Control Release, 119 (2007).

DOI: 10.1016/j.jconrel.2007.01.016

[4] K.L. Nair, S. Jagadeeshan, S.A. Nair and G.S. Kumar, Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA, Int. J. Nanomedicine. 6 (2011) 1685-1697.

DOI: 10.2147/ijn.s20165

[5] S. Parveen and S.K. Sahoo, Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery, Eur. J. Pharmacol. 670 (2011) 372-383.

DOI: 10.1016/j.ejphar.2014.02.009

[6] S. Zhou, X. Liao, X. Li, X. Deng and H. Li, Poly-D, L-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems, J. Control. Release. 86 (2003) 195-205.

DOI: 10.1016/s0168-3659(02)00423-6

[7] D. Mallardé, F. Boutignon, F. Moine, E. Barré, S. David, H. Touchet, P. Ferruti and R. Deghenghi, PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release, Int. J. Pharm. 261 (2003).

DOI: 10.1016/s0378-5173(03)00272-2

[8] J. Cheng, B.A. Teply, I. Sherifi, J. Sung, G. Luther, F.X. Gu, E. Levy-Nissenbaum, A.F. Radovic-Moreno, R. Langer, O.C. and Farokhzad, Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery, Biomaterials, 28 (2007).

DOI: 10.1016/j.biomaterials.2006.09.047

[9] S. Hu and Y. Zhang, Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation, Int. J. Nanomedicine. 24 (2010) 1039-1048.

DOI: 10.2147/ijn.s14753

[10] S. Cohen, T. Yoshioka, M. Lucarelli, L. H Hwang and R. Langer, Controlled delivery systems for pro teins based on poly(lactic/glycolic acid) microspheres, Pharm. Res. 8 (1991) 713–720.

[11] A. Roy, M.S. Singh, P.K. Upadhyay and S. Bhaskar, Combined chemoimmunotherapy as a prospective strategy to combat cancer: A nanoparticle based approach, Mol Pharm. 16 (2010) Epub ahead of print.

DOI: 10.1021/mp100153r